Recovery of hormone sensitivity after salvage brachytherapy for hormone refractory localized prostate cancer
AUTOR(ES)
Smith, Dan, Plowman, P. Nick
FONTE
International braz j urol
DATA DE PUBLICAÇÃO
2010-06
RESUMO
PURPOSE: Recent work has demonstrated the return of hormone sensitivity after palliative chemotherapy in androgen independent prostate cancer. We wished to establish whether a similar phenomenon existed in patients with no exposure to chemotherapy. MATERIALS AND METHODS: A review of “hormone resistant” patients who had received salvage brachytherapy for localized prostate cancer after previous external beam radiotherapy was undertaken. Three patients with subsequent biochemical relapse responded to the rechallenge with hormonal treatment. RESULTS: The series of patients presented here demonstrates this phenomenon occurs after salvage brachytherapy with no exposure to chemotherapy. Recovery of sensitivity is demonstrated both to androgen deprivation and to androgen receptor antagonism. The recovery of hormone sensitivity was surprisingly durable, ranging from eight months to over twenty-one months. CONCLUSIONS: Hormone sensitivity may be recovered after salvage brachytherapy. Potential mechanisms underlying these observations are discussed and the likely central role of the activity of the androgen receptor highlighted. The relevance of these findings to the management of advanced prostate cancer is considered including thoughts on the practice of intermittent anti-androgen therapy.
Documentos Relacionados
- Qualitay of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer
- Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer
- Clodronate for treatment of bone metastases in hormone refractory prostate cancer
- Quality of life after high-dose-rate brachytherapy monotherapy for prostate cancer
- Seed implant brachytherapy for prostate cancer